Terms: = Breast cancer AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523 AND Diagnosis
24 results:
1. Exploring the experiences of women living with metastatic breast cancer [MBC]: A systematic review of qualitative evidence.
Lyons-Rahilly T; Meskell P; Carey E; Meade E; O' Sullivan D; Coffey A
PLoS One; 2024; 19(1):e0296384. PubMed ID: 38181009
[TBL] [Abstract] [Full Text] [Related]
2. Treatment burden in individuals living with and beyond cancer: A systematic review of qualitative literature.
Adam R; Nair R; Duncan LF; Yeoh E; Chan J; Vilenskaya V; Gallacher KI
PLoS One; 2023; 18(5):e0286308. PubMed ID: 37228101
[TBL] [Abstract] [Full Text] [Related]
3. Barriers and Facilitators Influencing Arab Muslim Immigrant and Refugee Women's breast cancer Screening: A Narrative Review.
Racine L; Isik Andsoy I
J Transcult Nurs; 2022 Jul; 33(4):542-549. PubMed ID: 35473467
[TBL] [Abstract] [Full Text] [Related]
4. Human study on cancer diagnostic probe (cdp) for real-time excising of breast positive cavity side margins based on tracing hypoxia glycolysis; checking diagnostic accuracy in non-neoadjuvant cases.
Miripour ZS; Abbasvandi F; Aghaee P; Shojaeian F; Faramarzpour M; Mohaghegh P; Hoseinpour P; Namdar N; Hassanpour Amiri M; Ghafari H; Parniani M; Kaviani A; Alamdar S; NajafiKhoshnoo S; Sanati H; Mapar M; Sadeghian N; Akbari ME; Yunesian M; Abdolahad M
Cancer Med; 2022 Apr; 11(7):1630-1645. PubMed ID: 35224879
[TBL] [Abstract] [Full Text] [Related]
5. Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs.
Matsuda Y; Yamashita T; Ye J; Yasukawa M; Yamakawa K; Mukai Y; Machitani M; Daigo Y; Miyagi Y; Yokose T; Oshima T; Ito H; Morinaga S; Kishida T; Minamoto T; Yamada S; Takei J; Kaneko MK; Kojima M; Kaneko S; Masaki T; Hirata M; Haba R; Kontani K; Kanaji N; Miyatake N; Okano K; Kato Y; Masutomi K
J Pathol; 2022 Jun; 257(2):172-185. PubMed ID: 35094384
[TBL] [Abstract] [Full Text] [Related]
6. Combining contrast-enhanced ultrasound and blood cell analysis to improve diagnostic accuracy of plasma cell mastitis.
Zheng Y; Wang L; Han X; Shen L; Ling C; Qian Z; Zhu L; Dong F; Han Q
Exp Biol Med (Maywood); 2022 Jan; 247(2):97-105. PubMed ID: 34632855
[TBL] [Abstract] [Full Text] [Related]
7. An integrative review: Women's psychosocial vulnerability in relation to paid work after a breast cancer diagnosis.
Melnyk H; Djukic M; Merriman J; Vaughan Dickson V
J Adv Nurs; 2021 May; 77(5):2144-2154. PubMed ID: 33368563
[TBL] [Abstract] [Full Text] [Related]
8. Effectiveness of Adjuvant Ovarian Function Suppression in Premenopausal Women With Early breast cancer: A Multicenter Cohort Study.
Ferreira AR; Ribeiro J; Miranda A; Mayer A; Passos-Coelho JL; Brito M; Fernandes J; Gouveia J; Costa L; Vaz-Luis I
Clin Breast Cancer; 2019 Oct; 19(5):e654-e667. PubMed ID: 31327728
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of PIK3CA mutations as a biomarker in Chinese breast carcinomas from Western China.
Cheng J; Fu S; Wei C; Tania M; Khan MA; Imani S; Zhou B; Chen H; Xiao X; Wu J; Fu J
Cancer Biomark; 2017; 19(1):85-92. PubMed ID: 28269754
[TBL] [Abstract] [Full Text] [Related]
10. Barriers to early presentation and diagnosis of breast cancer among African women living in sub-Saharan Africa.
Akuoko CP; Armah E; Sarpong T; Quansah DY; Amankwaa I; Boateng D
PLoS One; 2017; 12(2):e0171024. PubMed ID: 28192444
[TBL] [Abstract] [Full Text] [Related]
11. Physical Activity During and After Adjuvant Treatment for breast cancer: An Integrative Review of Women's Experiences.
Browall M; Mijwel S; Rundqvist H; Wengström Y
Integr Cancer Ther; 2018 Mar; 17(1):16-30. PubMed ID: 28008778
[TBL] [Abstract] [Full Text] [Related]
12. Tumor detection using magnetosome nanoparticles functionalized with a newly screened EGFR/HER2 targeting peptide.
Xiang Z; Yang X; Xu J; Lai W; Wang Z; Hu Z; Tian J; Geng L; Fang Q
Biomaterials; 2017 Jan; 115():53-64. PubMed ID: 27888699
[TBL] [Abstract] [Full Text] [Related]
13. The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years.
Allen SD; Osin P; Nerurkar A
Eur J Surg Oncol; 2014 Jul; 40(7):824-9. PubMed ID: 24742589
[TBL] [Abstract] [Full Text] [Related]
14. Ethnic inequalities in time to diagnosis of cancer: a systematic review.
Martins T; Hamilton W; Ukoumunne OC
BMC Fam Pract; 2013 Dec; 14():197. PubMed ID: 24359157
[TBL] [Abstract] [Full Text] [Related]
15. breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies.
Shah C; Vicini FA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):907-14. PubMed ID: 21945108
[TBL] [Abstract] [Full Text] [Related]
16. Taurine: a novel tumor marker for enhanced detection of breast cancer among female patients.
El Agouza IM; Eissa SS; El Houseini MM; El-Nashar DE; Abd El Hameed OM
Angiogenesis; 2011 Sep; 14(3):321-30. PubMed ID: 21553281
[TBL] [Abstract] [Full Text] [Related]
17. Effectiveness of decentralized community-based screening, detection, and treatment of breast cancer in low-income, uninsured women.
Bhaskara A; Altamirano M; Trisal V; Paz IB; Lai LL
Am Surg; 2008 Oct; 74(10):1017-21. PubMed ID: 18942635
[TBL] [Abstract] [Full Text] [Related]
18. cancer diagnostics: decision criteria for marker utilization in the clinic.
Taube SE; Jacobson JW; Lively TG
Am J Pharmacogenomics; 2005; 5(6):357-64. PubMed ID: 16336001
[TBL] [Abstract] [Full Text] [Related]
19. Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells.
Popnikolov NK; Cavone SM; Schultz PM; Garcia FU
Mod Pathol; 2005 Dec; 18(12):1535-41. PubMed ID: 16258511
[TBL] [Abstract] [Full Text] [Related]
20. Physical activity and survival after breast cancer diagnosis.
Holmes MD; Chen WY; Feskanich D; Kroenke CH; Colditz GA
JAMA; 2005 May; 293(20):2479-86. PubMed ID: 15914748
[TBL] [Abstract] [Full Text] [Related]
[Next]
